Fibrin-dependent Plasminogen Activation, Binding Affinity to Fibrin and Fibrinolytic Activity of Lanoteplase (SUN 9216)

Japanese Pharmacology and Therapeutics

Volumn 27, Issue 2, 1999, Pages 24-25

  Oka, Naomi ^a   Furuya, Mayumi ^a   Hata, Kimiyo ^a   Okita, Naomi ^a   Komoriya, Kazumi ^a   Hayashi, Yujiro ^a   Inomata, Norio ^a   Okita, Tomochika ^a  

^a SUNTORY LTD   (Japan)

Author keywords

Fibrin; Fibrinolysis; Lanoteplase; Tissue plasminogen activator; Urokinase

Indexed keywords

ALTEPLASE; FIBRIN; LANOTEPLASE; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; FIBRINOLYSIS; HUMAN; PLASMINOGEN ACTIVATION;

EID: 0032974605     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. De Wood MA et al : Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303: 897-902, 1980
2. Rentrop KP : Thrombolytic therapy in patients with acute myocardial infarction. Circulation 71 : 627-631, 1985
3. Zamarron C et al : Biological and thrombolytic properties of proenzyme and active forms of human urokinase; Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinase obtained from human urine or recombinant DNA technology. Thrombos Haemostas 52 : 19-23, 1984
4. Hanaway J et al : Intracranial bleeding associated with urokinase therapy for acute ischemic hemisperal stroke. Stroke 7: 143-146, 1976
5. Thosen J et al : Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thromb Diathes Haemorrh 28: 65-74, 1972
6. Hoylaerts M et al : Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin J Biol Chem 257: 2912-2919, 1982
7. Van De Werf F et al : Coronary thrombolysis with tissue-plasminogen activator in patients with evolving myocardial infarction. N Engl J Med 310: 609-613, 1984
8. Collen D et al : Biological properties of human tissue-plasminogen activator obtained by expression of recombinant DNA in mammalian cells. J Pharmacol Exp Ther 231: 146-152, 1984
9. Verstraete M et al : Pharmacokinetic and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in human. J Pharmcol Exp Ther 235: 506-512, 1985
10. Sherry S : Tissue plasminogen activator (t-PA). Will it fulfill its promise? N Engl J Med 313: 1014-1017, 1985
11. Plasminogen Activator, Lanoteplase (1); 53: 1-10, 1997
12. Eastman D et al : Region of tissue plasminogen activation differentially with various fibrin(ogen)-related stimulators. Biochemistry 31: 419-422, 1982
13. Ranby M et al : A sensitive assay for tissue plasminogen activator. Thromb Res 27: 743-749, 1982
14. Lijnen HR, Collen D: Mechanisms of plasminogen activation by mammalian plasminogen activators. Enzyme 40: 90-96, 1988